George Sellers
Stock Analyst at Stephens & Co.
(1.35)
# 3,410
Out of 4,883 analysts
43
Total ratings
27.27%
Success rate
-6.3%
Average return
Main Sectors:
Stocks Rated by George Sellers
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ESTA Establishment Labs Holdings | Reiterates: Overweight | $68 | $43.40 | +56.68% | 7 | Aug 7, 2024 | |
| TFX Teleflex | Maintains: Overweight | $275 → $290 | $121.83 | +138.04% | 9 | Aug 2, 2024 | |
| VCEL Vericel | Maintains: Overweight | $56 → $58 | $41.55 | +39.59% | 2 | Aug 2, 2024 | |
| TMDX TransMedics Group | Maintains: Overweight | $151 → $178 | $130.10 | +36.82% | 2 | Aug 2, 2024 | |
| ANIK Anika Therapeutics | Reiterates: Equal-Weight | $24 | $10.53 | +127.92% | 6 | May 29, 2024 | |
| ENOV Enovis | Initiates: Overweight | $72 | $33.02 | +118.05% | 1 | Feb 13, 2024 | |
| APYX Apyx Medical | Maintains: Overweight | $8 → $5 | $2.27 | +120.26% | 2 | Nov 10, 2023 | |
| TMCI Treace Medical Concepts | Reiterates: Equal-Weight | $25 | $6.03 | +314.94% | 4 | Sep 12, 2023 | |
| STAA STAAR Surgical Company | Reiterates: Overweight | $57 | $17.02 | +234.90% | 6 | Aug 14, 2023 | |
| GKOS Glaukos | Reiterates: Overweight | $71 | $102.52 | -30.75% | 4 | May 8, 2023 |
Establishment Labs Holdings
Aug 7, 2024
Reiterates: Overweight
Price Target: $68
Current: $43.40
Upside: +56.68%
Teleflex
Aug 2, 2024
Maintains: Overweight
Price Target: $275 → $290
Current: $121.83
Upside: +138.04%
Vericel
Aug 2, 2024
Maintains: Overweight
Price Target: $56 → $58
Current: $41.55
Upside: +39.59%
TransMedics Group
Aug 2, 2024
Maintains: Overweight
Price Target: $151 → $178
Current: $130.10
Upside: +36.82%
Anika Therapeutics
May 29, 2024
Reiterates: Equal-Weight
Price Target: $24
Current: $10.53
Upside: +127.92%
Enovis
Feb 13, 2024
Initiates: Overweight
Price Target: $72
Current: $33.02
Upside: +118.05%
Apyx Medical
Nov 10, 2023
Maintains: Overweight
Price Target: $8 → $5
Current: $2.27
Upside: +120.26%
Treace Medical Concepts
Sep 12, 2023
Reiterates: Equal-Weight
Price Target: $25
Current: $6.03
Upside: +314.94%
STAAR Surgical Company
Aug 14, 2023
Reiterates: Overweight
Price Target: $57
Current: $17.02
Upside: +234.90%
Glaukos
May 8, 2023
Reiterates: Overweight
Price Target: $71
Current: $102.52
Upside: -30.75%